Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

5.68
Delayed Data
As of Dec 08
 -0.23 / -3.89%
Today’s Change
4.89
Today|||52-Week Range
20.46
-57.36%
Year-to-Date
 
Other institutional45.94%
Mutual fund holders11.61%
Individual stakeholders0.08%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

9/30/2016BLACKROCK FUND ADVISORS  Bought 601.1 Thousand shares of Cascadian Therapeutics In...
9/30/2016OPPENHEIM ASSET MANAGEMENT SERVI...  Bought 339.0 Thousand shares of Cascadian Therapeutics In...
10/31/2016APO ASSET MANAGEMENT GMBH  Bought 309.4 Thousand shares of Cascadian Therapeutics In...

Top 10 Owners of Cascadian Therapeutics Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
The Baupost Group LLC18.48%25,000,00025,750,00000.00%
BVF Partners LP13.89%18,799,36819,363,34900.00%
Franklin Advisers, Inc.5.10%6,899,6007,106,58800.00%
venBio Select Advisor LLC4.15%5,611,3235,779,663-133,400-2.32%
BlackRock Fund Advisors2.88%3,899,2864,016,265+601,074+18.22%
The Vanguard Group, Inc.2.57%3,481,0173,585,448+149,667+4.49%
Perceptive Advisors LLC2.52%3,414,1213,516,54500.00%
Oppenheim Asset Management Servic...0.77%1,034,4621,065,496+339,025+48.75%
FT Options LLC0.68%917,575945,102-200,086-17.90%
Medical Strategy GmbH0.66%886,188912,774+57,446+6.93%

Top 10 Mutual Funds Holding Cascadian Therapeutics Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change